| An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 RGW Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ... Cancer cell 17 (1), 98, 2010 | 7922 | 2010 |
| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 4900 | 2013 |
| Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 2873 | 2015 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1971 | 2016 |
| An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism I Dmitriev, V Krasnykh, CR Miller, M Wang, E Kashentseva, G Mikheeva, ... Journal of virology 72 (12), 9706-9713, 1998 | 956 | 1998 |
| Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor … CR Miller, DJ Buchsbaum, PN Reynolds, JT Douglas, GY Gillespie, ... Cancer research 58 (24), 5738-5748, 1998 | 461 | 1998 |
| Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob V Krasnykh, I Dmitriev, G Mikheeva, CR Miller, N Belousova, DT Curiel Journal of virology 72 (3), 1844-1852, 1998 | 460 | 1998 |
| An animal model of MYC-driven medulloblastoma Y Pei, CE Moore, J Wang, AK Tewari, A Eroshkin, YJ Cho, H Witt, ... Cancer cell 21 (2), 155-167, 2012 | 376 | 2012 |
| Glioblastoma CR Miller, A Perry | 318 | 2009 |
| Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types MD Wilkerson, X Yin, KA Hoadley, Y Liu, MC Hayward, CR Cabanski, ... Clinical cancer research 16 (19), 4864-4875, 2010 | 308 | 2010 |
| ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma SA Brooks, AR Brannon, JS Parker, JC Fisher, O Sen, MW Kattan, ... European urology 66 (1), 77-84, 2014 | 276 | 2014 |
| Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation MD Wilkerson, X Yin, V Walter, N Zhao, CR Cabanski, MC Hayward, ... PloS one 7 (5), e36530, 2012 | 259 | 2012 |
| Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class WC Rutledge, J Kong, J Gao, DA Gutman, LAD Cooper, C Appin, Y Park, ... Clinical Cancer Research 19 (18), 4951-4960, 2013 | 204 | 2013 |
| Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases A Perry, CR Miller, M Gujrati, BW Scheithauer, SC Zambrano, SC Jost, ... Brain Pathology 19 (1), 81-90, 2008 | 198 | 2008 |
| Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas CR Miller, CP Dunham, BW Scheithauer, A Perry Journal of clinical oncology 24 (34), 5419-5426, 2006 | 191 | 2006 |
| Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy L Yuan, M Siegel, K Choi, C Khosla, CR Miller, EN Jackson, ... Oncogene 26 (18), 2563-2573, 2007 | 189 | 2007 |
| A system for the propagation of adenoviral vectors with genetically modified receptor specificities JT Douglas, CR Miller, M Kim, I Dmitriev, G Mikheeva, V Krasnykh, ... Nature biotechnology 17 (5), 470-475, 1999 | 189 | 1999 |
| The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases CK Anders, AM Deal, CR Miller, C Khorram, H Meng, E Burrows, C Livasy, ... Cancer 117 (8), 1602-1611, 2011 | 177 | 2011 |
| HIF1α and HIF2α independently activate SRC to promote melanoma metastases SC Hanna, B Krishnan, ST Bailey, SJ Moschos, PF Kuan, T Shimamura, ... The Journal of clinical investigation 123 (5), 2078-2093, 2013 | 168 | 2013 |
| Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas CR Miller, CR Williams, DJ Buchsbaum, GY Gillespie Cancer research 62 (3), 773-780, 2002 | 157 | 2002 |
Carey AndersProfessor of MedicineVerified email at duke.edu
